Boston Scientific Corp. (BSX) Tops Q4 EPS by 5c, Offers Q1 Sales Guidance
Tweet
Share
E-mailGet Alerts BSX Hot Sheet
Price: $43.34 -0.48%
Revenue Growth %: +3.0%
Financial Fact:
Amortization expense: 136M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Revenue Growth %: +3.0%
Financial Fact:
Amortization expense: 136M
Today's EPS Names:
VIVO, OCCI, ALZN, More
Join SI Premium – FREE
Boston Scientific Corp. (NYSE: BSX) reported Q4 EPS of $0.13, $0.05 better than the analyst estimate of $0.08. Revenue for the quarter came in at $1.85 billion versus the consensus estimate of $1.91 billion.
Boston Scientific Corp. sees Q1 2012 revenue of $1.83-$1.9 million, versus the consensus of $1.9 million.
For earnings history and earnings-related data on Boston Scientific Corp. (BSX) click here.
Boston Scientific Corp. sees Q1 2012 revenue of $1.83-$1.9 million, versus the consensus of $1.9 million.
For earnings history and earnings-related data on Boston Scientific Corp. (BSX) click here.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Westinghouse said to seek over $50 billion valuation in planned IPO
- UBS cuts KOSPI target by nearly 10% to reflect higher rates
- Lumentum shares rise on analyst upgrades, AI demand outlook
Create E-mail Alert Related Categories
Earnings, GuidanceRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
